Skip to main content
SupplementScience

Andrographis Research & Evidence

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Moderate

Andrographis has an unusually strong evidence base for a herbal remedy. The Cochrane review by Hu et al. (2017) analyzed 33 RCTs with 7,175 participants, concluding that andrographis (alone or in combination) was superior to placebo for relieving cold symptoms. The standardized extract Kan Jang has been tested in multiple double-blind RCTs conducted in Sweden and other countries, showing consistent reductions in sore throat, nasal symptoms, and cough. Coon and Ernst (2004) conducted an earlier systematic review reaching similar conclusions. Andrographolide's anti-inflammatory mechanism via NF-kB inhibition is well-characterized and provides a pharmacological basis for its clinical effects.

Evidence by Condition

ConditionStudied DoseEvidence
Acute cold/flu treatment400-600mg extract daily for 5-7 daysModerate
Preventive immune support200-300mg extract dailyEmerging
Kan Jang preparation340mg SHA-10 3x dailyModerate

References

  1. (). Andrographis paniculata (Chuanxinlian) for symptomatic relief of acute respiratory tract infections in adults and children. Cochrane Database of Systematic Reviews. DOI
  2. (). Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Medica. DOI